(Q44163533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

title

Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

author name string

V Pittini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

D Teti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

C Arrigo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

G Aloi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

language of work or name

English

0 references

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

13 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12358938%20AND%20SRC:MED&resulttype=core&format=json

Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers

13 December 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.37694.X

Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.37694.X

Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.37694.X